PharmaBoardroom

New York: A Biotech Hub to Rival Boston & California?

Although Boston and California may be more internationally renowned as biotech hubs, New York is fast catching up. Thanks in large part to its strong…

France: AI & The Quest for Life Sciences 4.0

With Minister of the Economy and Finance, Bruno Le Maire, emphasizing the importance of “winning the battle on data” and eccentric mathematician…

French Cell & Gene Therapy: Finding the Funding

France – one of the most influential countries in the development of gene therapy– still stands as a global powerhouse in the field, with…

France’s Mid-Cap Pharma Champions Look to Global Markets

With a feel-good factor sweeping French innovative pharma, the country’s iconic mid-cap biopharma standard-bearers are once more on the rise. These…

Countering Korea’s Diabetes Epidemic, With AI?

Industry players - from Big Pharma giants to small local startups - are bringing new, innovative solutions to market in Korea in order to try and…

How Korea Built a World-Class Biosimilars Industry

The nation of South Korea has overtaken many of its regional counterparts to boast a highly impressive biosimilars pipeline. Here, key stakeholders in…

ISU Abxis: Charting a New Direction

ISU Abxis is a biotech company founded in 2001 with a focus on orphan drugs and rare disease. Part of the ISU chaebol, ISU Abxis has leveraged its…

Korea’s Medicine Man

CEO of the Life Science division of LG – one of Korea most recognized global brands – Dr Jeewoong Son has spent much of his career gathering the…

The Three Top Political Issues for Big Pharma

Eurasia Group’s Aditya Bhattacharji and Sarah Hassan identify and unpack the top three political and policy issues that multinational pharmaceutical…

AI: The Time is Right for a New Pharma Business Model

Dr Kamala Maddali looks at how artificial intelligence is currently being utilized across the healthcare spectrum and why the time is now for Big…

Chi Steve Chan – Chairman & CEO, Adimmune Corporation,…

Adimmune Corporation is the only influenza vaccine manufacturer with both EU GMP and US FDA certification in Asia, as well as the only PIC/S GMP…

Olav Fromm – Managing Director, Chiesi Nordics

Olav Fromm, managing director of Chiesi Nordics, explains the deep roots of Chiesi in Sweden, where its blockbuster drug, a surfactant for treating…

Tagged with